1633 results about "Cysteine" patented technology

A pharmaceutical composition comprising a protein arginine methyltransferase 5 (PRMT5) inhibitor and a KRASG12C (Kirsten rat sarcoma viral oncogene homolog glycine-to-cysteine) inhibitor. The pharmaceutical composition can be used for treating various cancers, comprising solid tumors. The combined product can be used for treating any number of diseases associated with PRMT5 and / or KRASG12C.

A method for visible light-mediated chemical modification of a polypeptide or protein based on cysteine includes the following steps: allowing a cysteine residue on a cysteine-containing oligopeptide, polypeptide, or protein to undergo a reaction with an activating reagent to generate a free radical precursor in situ; and subjecting the free radical precursor to desulfurization under photocatalytic condition, and allowing the generated free radical intermediate to undergo an addition reaction with an olefin or an alkyne, such that sulfhydryl removal and carbon-carbon bond construction are achieved to produce a chemical modification product of the polypeptide and protein. The method cleverly avoids the influence on the chiral center, and thus the chirality of the amino acid residue can be retained. The method is conducive to well avoiding the occurrence of side reactions, and thus the efficiency of the entire conversion is very high.

The invention discloses a 3 '-phosphoadenosine-5'-phosphoryl sulfate synthetase mutant and an application of the 3 '-phosphoadenosine-5'-phosphoryl sulfate synthetase mutant. Compared with a wild enzyme amino acid sequence as shown in SEQ ID NO.1, the amino acid sequence of the 3 '-adenosine-5'-phosphoryl sulfate synthetase mutant has one or two mutations in the 101 site, the 207 site and the 560 site; preferably, phenylalanine at the 101 site is mutated into tryptophan; cysteine at the 207th site is mutated into glycine; phenylalanine at the 560th site is mutated into tryptophan. The invention also provides a synthesis method and application of the 3 '-adenosine-5'-phosphoryl sulfuric acid. The APS intermediate product inhibition effect of hPAPSS1 is relieved through a point mutation technology, the substrate affinity of hPAPSS1 to ATP is improved, and a mutant enzyme with a high PAPS conversion rate is obtained; and the bifunctional enzyme hPAPSS1 is synthesized by heterologous expression of PAPS in escherichia coli, so that the acquisition of the enzyme is simplified, and the synthesis efficiency of PAPS is improved.

The present invention discloses a natural composite flavor enhancer and a preparation method thereof, comprising the following steps: using an ultramicro grinder to crush rice wine lees and wheat gluten powder to obtain ultramicro wheat gluten powder and ultramicro rice wine lees powder; taking the ultramicro wheat gluten powder, sterile water, and protease, mixing them evenly, carrying out enzymatic hydrolysis, inactivating the enzyme after the reaction ends, filtering, and taking the filtrate, namely the wheat gluten powder enzymatic hydrolysate, for standby; taking the wheat gluten powder enzymatic hydrolysate, ultramicro rice wine lees powder, and sterile water, mixing them evenly, carrying out enzymatic hydrolysis, inactivating the enzyme after the reaction ends, filtering, and taking the filtrate, namely the composite enzymatic hydrolysate, for standby; taking the composite enzymatic hydrolysate, cysteine, xylose, glucose, granulated sugar, and salt, mixing them and carrying out a thermal reaction to obtain a reaction solution; and preparing the natural flavor enhancer by spray drying. The present invention utilizes the natural enzyme system in rice wine lees to synergistically enzymatically hydrolyze wheat gluten powder to promote the release of umami amino acids, and further strengthens the umami by using thermal reaction technology.

The invention discloses a pharmaceutical composition for promoting angiogenesis and tissue regeneration and application thereof. The pharmaceutical composition of the present invention comprises an acidic secretory protein rich in cysteine, a disaccharide chain proteoglycan, and an XV-type collagen alpha1 chain. The biological material system loaded with the three types of proteins can promote angiogenesis, and can improve the tissue regeneration efficiency of bone, cartilage and skin defect areas.

The invention relates to the technical field of biology, and discloses a carbonyl reductase mutant and application thereof in enzymatic synthesis of chiral alcohol. The amino acid sequence as shown in SEQ ID NO.2 is subjected to mutation that 36th lysine is mutated into any one of aspartic acid, threonine and valine, or / and 125th histidine is mutated into any one of lysine, serine and leucine, or 170th histidine is mutated into any one of lysine, cysteine and leucine. The carbonyl reductase mutants, especially single-site mutants Mut-T75K, Mut-T75D and Mut-E216M and a combined mutant Mut-T75K-E216M, with activity improved to different extents compared with that of a wild type are obtained, have excellent relative enzyme activity, thermal stability and substrate tolerance, have relatively high activity and stability for various chiral alcohols, and can be used for preparing the carbonyl reductase mutants. The catalyst has the advantages of high catalytic activity, high thermal stability, strong substrate tolerance, easiness in fermentation and the like.

The invention provides a method for arylation and cyclization of polypeptide, and the reaction process is as follows: the specific method comprises the following steps: under weakly acidic, neutral or weakly alkaline conditions, carrying out a chemical selective arylation reaction on linear polypeptide II containing two cysteine residues through a dichloro nitrogen-containing heteroaromatic ring reagent I, so as to construct a cyclized stable polypeptide III. The cyclized stable polypeptide III has improved stability and cell transmembrane properties under physiological conditions.

The present invention is in the field of agricultural pathogen control. Methods and compositions are described for controlling plant diseases caused by pathogens, including fungi and oomycete phytopathogens. Chemicals were screened for activity as autophagy inhibitors. The screening method used a bioluminescence resonance energy transfer (BRET)-based high-throughput screening strategy to identify compounds that inhibit fungal ATG4 cysteine protease-mediated cleavage of ATG8 for autophagosome formation. Ebselen and ebselen analogs were identified as inhibitors of fungal pathogens ATG4-mediated ATG8 processing. Identified chemicals inhibit spore germination, hyphal development, and appressorium formation. The autophagy inhibitors significantly reduced the virulence of pathogens in their corresponding plant hosts. The invention also provides for compositions comprising the same, methods of making the same, and methods of controlling plant disease.

The invention relates to an indole hair dye based on air oxidation. The hair dye provided by the invention is characterized in that a chemical strong oxidant is not added, and oxygen in air can be catalyzed by using an air oxidation catalyst and a metal ion catalyst to naturally finish the oxidative polymerization process of indole substances (natural bionic melanin precursor substances). The used reducing agent is a combination of cysteine and a derivative thereof and sodium sulfite and a derivative thereof, the oxidative polymerization speed of indole substances can be controlled, and finally generated melanin macromolecules are embedded in hair cortex, so that white hair is obviously blackened. The natural oxidation process does not need hydrogen peroxide, destructive strong base or organic base, so that the use of harmful chemical reagents is reduced, the formula is simplified, the hair dyeing process is milder, potential hazards to hair and scalp are reduced, and the natural oxidation hair dye is safe, environmentally friendly and sustainable.

The invention relates to the technical field of carotenoid cleavage dioxygenase, and discloses a carotenoid cleavage dioxygenase mutant and application thereof. In order to improve the efficiency of converting carotenoid in tobacco into aroma molecule beta-ionone, specific mutation of characteristic sites is carried out on carotenoid cleavage dioxygenase (PhCCD1) from petunia, that is, serine (S) at the 428 site of the carotenoid cleavage dioxygenase is mutated into cysteine (C) or tyrosine (Y) to obtain a mutant S428C or S428Y, and the mutant S428C or S428Y is converted into beta-ionone. The yield of the beta-ionone converted from the carotenoid is greatly improved. Experiments prove that the yields of beta-ionone of S428C and S428Y respectively reach 54.2 mg / L and 50.6 mg / L, which are respectively increased by 69.7% and 58.5% compared with those of a wild strain WT.

The invention discloses a polypeptide with a whitening effect and a preparation method and application thereof.The polypeptide is obtained from hydrolyzed protein of babylonia areolata, the amino acid sequence of the polypeptide is cysteine-arginine-proline-threonine-cysteine-serine-arginine-leucine-alanine-cysteine, and the amino acid sequence of the polypeptide is cysteine-arginine-proline-threonine-cysteine-serine-arginine-leucine-alanine. The compound can obviously inhibit the generation of melanin in cells and the activity of tyrosinase in vitro, has the characteristics of low toxicity, low irritation, good stability, safety and high efficiency, and can be applied to whitening cosmetics.

The invention relates to the field of plant molecular biology and forest genetic engineering, and particularly provides a PagRAP2.3 protein point mutant and application thereof in drought resistance of poplar. The mutant PagRAP2.3 MA is obtained by mutating methionine at the first site and cysteine at the second site of a wild type PagRAP2.3 protein into methionine and alanine. The invention further discloses a preparation method of the mutant PagRAP2.3. An expression vector containing the PagRAP2.3 MA gene is constructed, poplar 84K is transformed through an agrobacterium-mediated method, and a transgenic line with stable expression is obtained. Functional verification results show that overexpression of PagRAP2.3 MA can significantly increase the plant height of the poplar and promote plant growth, but the sensitivity to moisture is enhanced under drought stress. The mutant can be used for regulating and controlling the growth and development of forest trees and evaluating the drought resistance, and has a forestry breeding application prospect.

The invention discloses a solid-phase microextraction derived fiber head and a preparation method and application thereof, the solid-phase microextraction derived fiber head comprises a solid-phase matrix and polystyrene microspheres adhered to the surface of the solid-phase matrix, and a chitosan cross-linked network layer is also cross-linked on the polystyrene microspheres; cysteine is also adsorbed on the polypropylene microsphere and chitosan cross-linked network layer. According to the solid-phase microextraction derivative fiber head, a large number of hydrophilic action sites such as amino groups and carboxyl groups exist on the surface, so that synchronous extraction and detection of the contents of three target analytes, namely cysteine-chlorothalonil association compounds, sulfydryl chlorothalonil and hydroxychlorothalonil, are realized.

The invention belongs to the technical field of biological medicine, and particularly relates to application of anethomycin in preparation of medicine for inhibiting cysteine protease activity. The invention discovers that anethomycin has the function of inhibiting the activity of virus cysteine protease, especially 3C or 3CL protease, for the first time. Molecular docking proves that anethomycin can effectively bind to the catalytic activity center of Senecavirus (SVA) 3C protease. An in-vitro FRET enzyme activity experiment proves that the inhibition rate of 50 [mu] M of anethomycin on SVA 3C protease reaches up to 88.5%. Cellular level experiments show that the anethomycin can significantly inhibit replication of SVA viruses, shows broad-spectrum antiviral activity on various viruses such as encephalomyocarditis viruses (EMCV), porcine reproductive and respiratory syndrome viruses (PRRSV) and porcine deltacoronaviruses (PDCoV), and is low in cytotoxicity and high in selectivity index (SI).

The invention provides a functional nanofiber material as well as a preparation method and application thereof, and the preparation method comprises the following steps: (1) adding raw materials into water to form an electrostatic spinning solution; performing electrostatic spinning to obtain a nanofiber membrane; (2) cross-linking the nanofiber membrane in an organic solvent under the catalysis of acid to obtain a cross-linked nanofiber membrane; and (3) carrying out grafting reaction on the cross-linked nanofiber membrane in a polyamine cross-linking agent, and then reacting with a sulfur-containing reagent to obtain the functional nanofiber material, the functionalized nanofiber material prepared by the preparation method disclosed by the invention combines good biocompatibility of polyvinyl alcohol, high specific surface area and high porosity of nanofiber and a synergistic adsorption effect of the polyamine cross-linking agent and cysteine, and has the advantages of large adsorption capacity, high adsorption rate, strong selectivity, good biocompatibility, stable structure and the like; the heavy metal ions in the plasma can be efficiently and safely removed, and a plurality of defects of the existing adsorption material are overcome.

The invention discloses a compound environment-friendly corrosion inhibitor as well as a preparation method and application thereof. The choline ionic liquid comprises choline ionic liquid and amino acid, the choline ionic liquid is choline cations; the amino acid is one or more of cysteine and tryptophan. The compound environment-friendly corrosion inhibitor has high corrosion inhibition efficiency, and the compound structure of the compound environment-friendly corrosion inhibitor further improves the protection performance of the compound environment-friendly corrosion inhibitor through a dual adsorption mechanism of the synergistic effect of physical adsorption and chemical adsorption on the metal surface. According to the compound environment-friendly corrosion inhibitor, a full-green ionic liquid corrosion inhibition system is constructed, the environment-friendly requirement is met, and a metal protection solution can be provided for industrial acid pickling and other strong acid working conditions. Not only is the progress of a corrosion inhibition technology promoted, but also more economic and environment-friendly anti-corrosion application can be provided for actual industrial scenes.

The invention belongs to the technical field of electro-catalytic materials and carbon dioxide emission reduction and resource utilization, and particularly relates to an amino acid modified copper-based catalyst and a preparation method and application thereof. According to the catalyst, the surface of cuprous oxide with an orthorhombic-section semi-cube shape is modified through L-cysteine, and a composite structure with a special interface microenvironment is formed. Sulfydryl in L-cysteine and copper species on the surface of cuprous oxide can form a strong coordination effect, water decomposition and * CO protonation are promoted, the surface structure is stabilized, asymmetric coupling is facilitated, meanwhile, amino can provide an electron-rich environment, capture of carbon dioxide is enhanced, and the selectivity and stability of ethylene prepared through electro-catalysis carbon dioxide reduction are cooperatively regulated and controlled.

The invention discloses a method for realizing high-efficiency selenium labeling of protein, which comprises the following steps of: in the process of expressing plasmids containing target protein through a prokaryote expression system, realizing high-efficiency replacement of cysteine sulfur atoms in the target protein by selenium atoms by regulating and controlling the ratio of selenium to sulfur elements in a culture medium; on the premise of keeping a good growth state of cells, the selenium labeling efficiency can reach 86%, and the protein expression quantity is stabilized at about 1mg / g (protein / thallus wet weight); structural analysis shows that the secondary structure of the obtained selenium-labeled protein is basically consistent with that of natural protein and is not obviously changed. The method is easy and convenient to operate, high in labeling efficiency, high in protein yield, good in repeatability and suitable for structural biology research such as nuclear magnetic resonance, an effective means is provided for research of the functional mechanism of sulfur atoms in biomacromolecules (including small peptides, polypeptides, peptide fragments, proteins and protein or peptide complexes) with selenium as a probe, and the method has a wide application prospect. Good scientific research application prospects and industrial popularization values are realized.

The invention discloses a saccharomycetes lysate, a preparation method and application, and the main components of the saccharomycetes lysate comprise the following components accounting for the relative content of the saccharomycetes lysate: 93-98% of nucleoside, nucleotide and derivatives thereof; and 0.2 to 6% of amino acid; wherein the nucleoside, the nucleotide and the derivatives of the nucleoside and the nucleotide comprise one or more of adenosine, succinyladenosine, adenosine-3 '-phosphoric acid, inosine and S-adenosine homocysteine. Effect evaluation is carried out on the saccharomycetes lysate, and verification shows that the saccharomycetes lysate has the effects of whitening, repairing skin injury, preventing light and aging, resisting pollution and oxidation, resisting inflammation and relieving, protecting hair and preventing hair loss, replenishing water and preserving moisture, and enhancing skin vitality or removing dark circles.

The invention discloses a human small cell lung cancer brain metastasis organoid culture medium and a culture method. According to the culture medium, an advanced DMEM / F12 culture medium is used as a basic culture medium, and the following components are added: 2 to 5 [mu] M of GlutaMax, 8 to 10 [mu] M of HEPES, 1 * to 2 * of B27, 500 [mu] M of SB202190, 5 to 10 [mu] M of Y-27632, 0.5 [mu] M of A83-01, 0.5 to 2 [mu] M of N-Acetyl-L-cysteine, 5 mM of Nicotinamide, 25 to 100 ng / ml of recombinant human FGF7, 100 to 500 ng / ml of recombinant human FGF10, 100 to 200 ng / ml of Human Noggin, 50 to 500 ng / ml of Human R-Spondin-1, 50 to 100 ng / ml of According to the culture method, TryPLE Express is used for dissociation, the time is short, the activity of dissociated single cells is high, and the success rate of organoid culture can be increased to the maximum extent. Meanwhile, by combining with a culture medium with an optimized formula proportion, formation and growth of brain metastatic organs of the human small cell lung cancer can be promoted, and the construction success rate is increased.

The invention relates to the technical field of biology, and discloses a recombinant carbonyl reductase mutant and application thereof in synthesis of chiral alcohol. According to the invention, the 36th-site lysine is mutated into any one of aspartic acid, threonine and valine, or / and the 125th-site histidine is mutated into any one of lysine, serine and leucine, or / and the 170th-site histidine is mutated into any one of lysine, cysteine and leucine; the carbonyl reductase mutants, especially single-site mutants Mut-K36D and Mut-H125K and a combined mutant Mut-K36D-H125K, with activity improved to different extents compared with that of a wild type are obtained, have excellent thermal stability and relative enzyme activity, have relatively high activity and stability aiming at various chiral alcohols, and can be used for preparing the carbonyl reductase. The method has the advantages of high catalytic activity, high enzyme expression quantity, easiness in fermentation and the like.

The invention belongs to the technical field of medicines, and particularly relates to a hydrogel dressing for promoting healing of diabetic wounds as well as a preparation method and application of the hydrogel dressing. According to the hydrogel dressing for promoting healing of the diabetic wound, glycyrrhizic acid and S-allyl-L-cysteine are used as raw materials, a buffer solution is used as a dispersion medium, and the glycyrrhizic acid and S-allyl-L-cysteine are compounded and self-assembled by controlling the mass ratio of the raw materials, the reaction temperature, the reaction time and the pH value. The hydrogel shows tissue-like viscoelasticity characteristics, can adaptively deform along with wound movement, provides continuous protection for chronic wounds under dynamic physiological conditions, and has flexibility of adapting to dynamic requirements in different healing stages.

The invention provides an electrolyte additive for synergistically regulating and controlling activity and stability of an all-vanadium redox flow battery and application of the electrolyte additive, the electrolyte additive is a composite additive of an organic amino acid compound and inorganic phosphate, the organic amino acid compound is one of aspartic acid, glycine and cysteine, and the inorganic phosphate is one of amino acid, glycine and cysteine. The inorganic phosphate is one or two or more of phosphate, dihydric phosphate, dihydric phosphate, polyphosphate and pyrophosphate, and cations of the inorganic phosphate are one or two or more of potassium, sodium and ammonium salt. The composite additive is used as an electrolyte additive to be added into an all-vanadium redox flow battery electrolyte, so that the vanadium electrolyte can be effectively prevented from generating precipitates at high temperature, the capacity fading in the battery operation process is avoided, and the stable operation of the battery is realized. The preparation process is simple to operate, energy-saving, environment-friendly and low in cost, and stable operation of the electrolyte in the battery can be realized.

In the first aspect, the present disclosure provides a Lactoferrin polypeptide fragment, where the Lactoferrin polypeptide fragment has an amino acid sequence shown in SEQ ID NO: 1. In the second aspect, the present disclosure provides a preparation method of the Lactoferrin polypeptide fragment, including: protecting amino acids using a 9-fluorenylmethoxycarbonyl (Fmoc) protecting group, coupling the amino acids with a P-hydroxymethylphenoxymethyl polyethylene resin (HMP resin) in an order of cysteine, alanine, leucine, cysteine, glutamate, threonine, asparagine, aspartate, asparagine, phenylalanine, leucine, leucine, asparagine, and lysine, and separating the HMP resin to obtain a target Lactoferrin polypeptide fragment. In the third aspect, the present disclosure further provides an anti-Lactoferrin antibody prepared using the Lactoferrin polypeptide fragment, and use of the Lactoferrin polypeptide fragment in preparation of an anti-Lactoferrin flow cytometric antibody and in preparation of a Lactoferrin detection product.

Provided herein are self-assembling collagen-like peptide (CLP) comprising a plurality of amino acid trimer repeats having the amino acid sequence POG, wherein P is a proline, O is an hydroxyproline or a cysteine, and G is a glycine or a valine. Also provided herein are compositions, scaffolds, photoactivatable hydrogel precursors and hydrogels comprising the CLP and a multi-arm polyethylene glycol (PEG) polymer. Methods of preparing photoactivatable hydrogel precursors and hydrogels are also described. Methods of treating a wound, of treating a corneal disease, of treating a myocardial infarct, of promoting cell growth and of treating cellular degeneration using the compositions, scaffolds, photoactivatable hydrogel precursors and / or hydrogels are also described. Also provided is a device for delivering a peptide-based material. The device comprises an on / off button or switch for initiating and stopping delivery of the peptide-based material in the subject; a chamber for containing the peptide-based material; an aperture through which the peptide-based material exits the chamber, wherein the aperture is adapted for receiving a nozzle adapter; a camera port for securing a camera thereto; and a digital control display.

The invention discloses an amino acid composition for treating alopecia and application of the amino acid composition in preparation of a medicine for treating alopecia, and belongs to the field of medicine configuration products, the amino acid composition is composed of a targeting core intervention component and an auxiliary strengthening synergistic component, the targeting core intervention component is prepared from 30-50 parts of arginine, 50-155 parts of lysine and 50-120 parts of glutamic acid, and the auxiliary strengthening synergistic component is prepared from an auxiliary strengthening synergistic component and an auxiliary strengthening synergistic component. 10 to 40 parts of cysteine and 20 to 60 parts of leucine; the auxiliary strengthening synergistic component is prepared from 15 to 45 parts of tyrosine, 15 to 40 parts of glycine, 10 to 40 parts of glutamine, 20 to 35 parts of serine, 5 to 25 parts of alanine, 2 to 20 parts of aspartic acid and 15 to 35 parts of phenylalanine; the composition can be used as an active ingredient to be prepared into different dosage forms such as a pigmentum, a spray, an ointment and a liniment, is applied to prevention of alopecia and promotion of hair growth, and has a remarkable treatment effect.

The invention discloses a low-foam acidic zinc plating additive and a preparation process thereof, and belongs to the technical field of electroplating additives, the additive comprises a low-foam softening agent and a water-based brightener, and the low-foam softening agent comprises the following raw materials in percentage by mass: 0.8-1.2% of polyethyleneimine, 0.03-0.06% of monododecyl phosphate potassium, 0.2-0.6% of water-soluble polyether amine and the balance of water. The water-based brightener is prepared from the following raw materials: 0.6 to 1.2 percent of 5-hydroxymethylfurfural, 0.2 to 0.4 percent of L-cysteine salt, 0.1 to 0.15 percent of 4-amino-2 (1H) pyrimidone, 0.05 to 0.1 percent of sodium salicylate, 1 to 1.5 percent of citric acid, 0.3 to 0.5 percent of alpha-ketoglutaric acid, 0.2 to 0.4 percent of erythorbic acid and the balance of water. The water-based formula is prepared by optimizing the components in the additive, the components are uniformly dispersed, the foam amount is low, and the plating quality is good.

The invention provides a preparation method and application of an intestinal adhesion delivery system based on pea 2S albumin. The intestinal adhesion delivery system is a protein-polyphenol compound generated by covalent binding of quinone obtained by oxidizing polyphenol through periodate resin and pea 2S albumin. According to the intestinal adhesion delivery system, cysteine-rich pea 2S albumin is used as a delivery carrier, polyphenol bioactive substances are loaded on the cysteine-rich pea 2S albumin, release of functional components in the digestion process is effectively delayed, and the gastrointestinal stability is improved. The composition is applied to the fields of inflammatory bowel diseases and intestinal infection, can target the diseased region of colitis, and effectively relieves the symptoms of colitis by enhancing the barrier function of intestinal mucosa, regulating intestinal flora and inhibiting inflammatory response. The intestinal adhesion delivery system can also deliver other bioactive substances, is applied to the fields of biological science, functional food and the like, and has good development potential.

The invention discloses a plant source leaf surface resistance and control agent for efficiently reducing the cadmium content of wheat and a preparation method thereof. According to the invention, S-allyl-L-cysteine is used as an important component of the foliar blocking and controlling agent, so that the bioavailability of cadmium ions is effectively reduced, and the absorption and transport of cadmium in plants are reduced, thereby reducing the cadmium content in wheat grains. Meanwhile, S-allyl-L-cysteine has relatively strong antioxidant capacity, so that free radicals in the plant body can be removed, and cells are protected from oxidative damage. As a plant growth regulator, S-allyl-L-cysteine can improve nutrient absorption and utilization of plants and promote photosynthesis and energy metabolism of the plants, so that the yield and quality of wheat are improved. The S-allyl-L-cysteine can activate a defense mechanism in a plant body, enhance the resistance of the plant to environmental stress, including the resistance to heavy metal pollution, and improve the overall health and yield of wheat.

The invention provides a probiotic mixed fermentation method for enhancing a synergistic effect. Lactobacillus plantarum, bifidobacterium longum and clostridium tyrobutyricum are inoculated according to a volume ratio, and a pH-triggered two-stage fermentation process is adopted: the first stage is micro-aerobic to drive lactic acid bacteria to quickly produce acid, and the second stage is anaerobic to directionally improve butyric acid synthesis by pulse feeding of inulin-cysteine sustained-release particles. Physical isolation of flora is realized by using a double-layer gradient carrier, lactic acid bacteria are immobilized by sodium alginate-gelatin gel on the outer layer to form an acid barrier, and bifidobacterium and butyric acid producing bacteria are co-immobilized by chitosan microspheres on the inner layer to construct an anaerobic microenvironment. The technology breaks through the competitive inhibition bottleneck of multi-strain fermentation, the total number of viable bacteria is increased by 150% compared with a traditional technology, the yield of butyric acid is increased by 355%, and the technology is suitable for large-scale production of functional food and pharmaceutical preparations.